SEARCH

SEARCH BY CITATION

References

  • Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J.H., Lanier, L.L. & Spies, T. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 285, 727729.
  • Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189199.
  • Bessler, M., Mason, P., Hillmen, P. & Luzzatto, L. (1994) Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet, 343, 951953.
  • Chen, R., Nagarajan, S., Prince, G.M., Maheshwari, U., Terstappen, L.W., Kaplan, D.R., Gerson, S.L., Albert, J.M., Dunn, D.E., Lazarus, H.M. & Medof, M.E. (2000) Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria. Journal of Clinical Investigation, 106, 689696.
  • Chen, G., Kirby, M., Zeng, W., Young, N.S. & Maciejewski, J.P. (2002) Superior growth of glycophosphatidy linositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo. Experimental Hematology, 30, 774782.
  • Coluzzi, S., Biffoni, M., Pasqualetti, D., Perrone, M.P., Vaglio, S., Rahimi, H., Arista, M.C., Laurenti, L., Cerretti, R. & Girelli, G. (2004) Production of interferon-gamma by lymphocytes from paroxysmal nocturnal haemoglobinuria patients: relationship with clinical status. British Journal of Haematology, 124, 685690.
  • Cosman, D., Mullberg, J., Sutherland, C.L., Chin, W., Armitage, R., Fanslow, W., Kubin, M. & Chalupny, N.J. (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity, 14, 123133.
  • Gasser, S. & Raulet, D.H. (2006) The DNA damage response arouse the immune system. Cancer Research, 66, 39593962.
  • Hanaoka, N., Kawaguchi, T., Horikawa, K., Nagakura, S., Mitsuya, H. & Nakakuma, H. (2006) Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP. Blood, 107, 11841191.
  • Hertenstein, B., Wagner, B., Bunjes, D., Duncker, C., Raghavachar, A., Arnold, R., Heimpel, H. & Schrezenmeier, H. (1995) Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma. Blood, 86, 14871492.
  • Horikawa, K., Fujisao, S., Iwamoto, N., Nagakura, S., Kawaguchi, T., Nishimura, Y., Takatsuki, K. & Nakakuma, H. (1996) Cyclosporin-responsive pancytopenia and HLA class II alleles of a patient with paroxysmal nocturnal hemoblobinuria. International Journal of Hematology, 63, 165166.
  • Horikawa, K., Nakakuma, H., Kawaguchi, T., Iwamoto, N., Nagakura, S., Kagimoto, T. & Takatsuki, K. (1997) Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood, 90, 27162722.
  • Inoue, N., Murakami, Y. & Kinoshita, T. (2003) Molecular genetics of paroxysmal nocturnal hemoglobinuria. International Journal of Hematology, 77, 107112.
  • Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, pp. 135137. IARC Press, Lyon, France.
  • Jamieson, A.M., Diefenbach, A., McMahon, C.W., Xiong, N., Carlyle, J.R. & Raulet, D.H. (2002) The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity, 17, 1929.
  • Karadimitris, A., Manavalan, J.S., Thaler, H.T., Notaro, R., Araten, D.J., Nafa, K., Roberts, I.A., Weksler, M.E. & Luzzatto, L. (2000) Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood, 96, 26132620.
  • Kawaguchi, T. & Nakakuma, H. (2007) New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria. International Journal of Hematology, 86, 2732.
  • Kawano, F., Chosa, M., Matsuoka, M., Oyamada, N. & Takatsuki, K. (1987) Paroxysmal nocturnal hemoglobinuria: Termination in acute monocytic leukemia and reappearance after chemotherapy with N4-palmitoyl-1-b-D-arabinofuranosylcytosine (PL-AC) and vincristine. Japanese Journal of Clinical Oncology, 17, 123128.
  • Kubin, M., Cassiano, L., Chalupny, J., Chin, W., Cosman, D., Fanslow, W., Mullberg, J., Rousseau, A.M., Ulrich, D. & Armitage, R. (2001) ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. European Journal of Immunology, 31, 14281437.
  • Murakami, Y., Kosaka, H., Maeda, Y., Nishimura, J., Inoue, N., Ohishi, K., Okabe, M., Takeda, J. & Kinoshita, T. (2002) Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria. Blood, 100, 41164122.
  • Nagakura, S., Ishihara, S., Dunn, D.E., Nishimura, J., Kawaguchi, T., Horikawa, K., Hidaka, M., Kagimoto, T., Eto, N., Mitsuya, H., Kinoshita, T., Young, N.S. & Nakakuma, H. (2002) Decreased susceptibility of leukemic cells with PIGA mutation to natural killer cells in vitro. Blood, 100, 10311037.
  • Nakakuma, H. & Kawaguchi, T. (2003) Pathogenesis of selective expansion of PNH clones. International Journal of Hematology, 77, 121124.
  • Nakao, S., Takamatsu, H., Chuhjo, T., Ueda, M., Shiobara, S., Matsuda, T., Kaneshige, T. & Mizoguchi, H. (1994) Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood, 84, 42574261.
  • Parker, C.J. & Ware, R.E. (2003) Paroxysmal nocturnal hemoglobinuria. In: Wintrobe’s Clinical Hematology (eds by J.P.Greer, F.Foerster, J.N.Leukens, G.M.Rodgers, F.Paraskevas & B.Glader), 11th edn, pp. 12031221. Lippincott Williams and Wilkins, Baltimore, MD.
  • Parker, C., Omine, M., Richards, S., Nishimura, J., Bessler, M., Ware, R., Hillmen, P., Luzzatto, L., Young, N., Kinoshita, T., Rosse, W. & Socie, G. & for the International PNH Interest Group. (2005) Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood, 106, 36993709.
  • Raulet, D.H. (2003) Roles of the NKG2D immunoreceptor and its ligands. Nature Reviews Immunology, 3, 781790.
  • Risitano, A.M., Kook, H., Zeng, W., Chen, G., Young, N.S. & Maciejewski, J.P. (2002) Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry. Blood, 100, 178183.
  • Risitano, A.M., Maciejewski, J.P., Muranski, P., Wlodarski, M., O’Keefe, C., Sloand, E.M. & Young, N.S. (2005) Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients. Leukemia, 19, 217222.
  • Salih, H.R., Antropius, H., Gieseke, F., Lutz, S.Z., Kanz, L., Rammensee, H.-G. & Steinle, A. (2003) Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood, 102, 13891396.
  • Sugimori, C., Chuhjo, T., Feng, X., Yamazaki, H., Takami, A., Teramura, M., Mizoguchi, H., Omine, M. & Nakao, S. (2006) Minor population of CD55CD59 blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood, 107, 13081314.
  • Vales-Gomez, M., Chisholm, S.E., Cassady-Cain, R.L., Roda-Navarro, P. & Reyburn, H.T. (2008) Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors. Cancer Research, 68, 15461554.
  • Vilarinho, S., Ogasawara, K., Nishimura, S., Lanier, L.L. & Baron, J.L. (2007) Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proceedings of the National Academy of Sciences of the United States of America, 104, 1818718192.
  • Young, N.S. (2000) Bone Marrow Failure Syndromes. Saunders, Philadelphia, PA.